3 assets in Muscular Dystrophy, Cardiac Type

Therapeutic assets addressing Muscular Dystrophy, Cardiac Type, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Empagliflozin Muscular Dystrophy, Cardiac Type	Sebastiano Lava	P2	CCC (53)
Talfirastide Muscular Dystrophy, Cardiac Type	Constant Therapeutics LLC	P2	CCC (53)
Srd-001 Muscular Dystrophy, Cardiac Type	Sardocor Corp.	P1	CC (43)